Lung cancer is the leading cause of death in Mexico due to malignant tumors.
Annually, 8,600 new cases are diagnosed and almost the same number, 8,000, died in that period.
ONLY 0.6% of cases are diagnosed early, 24% at the locally advanced stage and 65% at the terminal
stage.
It is not only caused by smoking, but also by exposure to smoke and pollutants.
22 people die daily due to lung cancer in Mexico.
Because it can NOT be detected early, the disease is diagnosed in advanced stages and spreads very
quickly, since 90% of patients die before 18 months after being diagnosed.
People suffering from this pathology only go to the medical service until they are in an advanced
period.
Worldwide, lung cancer occupies the first place of incidence and mortality, represents the main
health problem in the field of Oncology and one of the most important in general, being the 10th
cause of death worldwide.
A high number of cases are NOT registered and are not even reported as lung cancer because the
patient dies with a diagnosis of pneumonia or tuberculosis or other diseases. Therefore, it is
considered that the disease is sub-registered.
The vast majority of diagnoses are made when the tumors already measure 3 or 4 centimeters and there
are clinical manifestations.
It is estimated that if people considered at high risk of lung cancer were screened early, mortality
would be reduced by 20%
Lung cancer is the leading cause of death in Mexico due to malignant tumors.
It is not only caused by smoking, but also by exposure to smoke and pollutants.
Worldwide, lung cancer ranks first in incidence and mortality
CONCLUSION: EARLY DETECTION GENERATES A TIMELY DIAGNOSTIC AND TRANSLATES IN A GREAT OPPORTUNITY TO SAVE LIVES.
Lung cancer can affect anyone:
Risk factors for lung cancer include:
STAGES OF LUNG CANCER:
CANCER OF SMALL CELLS | CANCER OF NON-SMALL CELLS |
---|---|
It is considered from 10 to 20% of cancer. | It represents the remaining 80 - 90% of the cancer. |
For small cell lung cancer, the models to determine the stage in which it is found, are based on the premise of how large the tumor has grown, for example, if it has reached nearby structures or if it has spread to organs or in lymph nodes. The stages are described in scales from 0 to 4; in stage 0, there are no lesions detectable by imaging methods, but abnormalities are found in procedures such as bronchoscopy; Stage 4 shows cancer that has already spread to other parts of the body.
Small cell cancer has 2 stages: Extensive and Limited.
NOTE: THE STAGE IN WHICH CANCER IS ESTABLISHED IS ONE OF
THE MOST IMPORTANT FACTORS TO WORK IN YOUR TREATMENT.
CONCLUSION: EARLY DETECTION GENERATES TIMELY DIAGNOSTIC AND TRANSLATES IN A GREAT OPPORTUNITY TO SAVE
LIVES.
FREQUENTLY ASKED QUESTIONS:
Why does a BreathLab test work better? Traditional checkups for lung diseases are carried out on a regular basis by techniques such as x-rays. Small shadows can be ignored or ignored, as they are seen as possible benign nodules or damage from other diseases. Treatment may be delayed due to a misinterpretation of the plaque during the early stages of cancer. The tumor grows undetected and can only be diagnosed in stages where it is already larger and its treatment becomes more difficult. With the support of BreathLab, the story may be different, it is estimated that thanks to BreathLab technology, we can detect lung cancer molecules up to 5 years before they are clinically apparent.
SIZE / VISIBILITY | DETECTION |
---|---|
0mm | Tumors can be detected up to 5 years before they are visible. |
2mm | Tumors can be detected by high-resolution CT technology. |
8mm | Tumors can be clearly detected by CT. |
40mm | The tumors are clinically apparent and there are physical symptoms present. |
100mm | Death cause |
When a tumor is present in the body, molecules are released into the bloodstream. When
exhaled, BreathLab technology can detect the Volatile Organic Compounds (VOCs) present in the sample up
to 5 years before they become clinically apparent.
Nowadays
,traditional methods for the detection of lung cancer (X-ray / CT scan) ) are associated with radiation
exposure to the patient, which can be harmful to health if it is repetitive.
METHOD | SENSITIVITY | SPECIFICITY | METHODOLOGY | PRECISION | HEALTH DAMAGE |
---|---|---|---|---|---|
BreathLab | 41% | 91% | Metabolomas in breath. | 92% | DO NOT |
Scanning | 70% | 50% | Lodge image | 50% | Exposure to radiation. |